Kevin Lin

Kevin Lin brings extensive expertise in finance, capital markets, and commercial strategy to ClusterFree's Advisory Board. He is also a cluster headache patient of over 20 years, whose personal experience has driven his commitment to increasing access to effective treatments globally.

As a finance executive and investor, Kevin has spent over a decade building companies, leading investments, and raising capital across regulated industries, including pharma, fintech, and technology. He formerly served as Executive Director at Morgan Stanley's $3.5bn opportunistic investment arm, where he led pharma and technology investments. He holds an AB in economics from Harvard University.